High-margin, Scalable Gut Health Business For Acquisition Or Investment – Uk

Exclusive UK & Ireland rights to the world’s most clinically proven probiotic formulation, currently achieving €75M+ in global sales per year.

Previously sold under a different brand name in the UK, this clinically validated formulation has annual sales of £932,000. It has since been relaunched under a new brand, with exclusive distribution rights secured for the UK and Irish markets.

Proven early traction: €280K in Irish revenue (2024) with 56% net margins; UK site now live and showing early growth signals.

Highly scalable model: Fully outsourced operations, next-day fulfilment, and an ultra-lean setup ready to support 10x growth.

Flexible investment opportunity: Up to 50% equity stake available for strategic partners, or full acquisition considered.

The business is fully operational in both the UK and Ireland, with all infrastructure, logistics, and fulfilment systems in place. The business is profitable, lean, and built to scale rapidly.

The founder is now seeking a strategic partner to unlock the next stage of growth—funding marketing expansion, inventory scale-up, and B2B development. A full exit is also an option for the right acquirer with the vision and capability to take the brand to the next level.